$175,000,000 cash raised to open the door for the launch of 4Kscore
OPKO Health will Launch a product that will revolutionize the urology field. $175,000,000 raised from the CEO (Dr, Frost) to invest in the nationwide distribution of OPKO's new patient, 4Kscore. 4Kscore will change the way prostate testing for cancer will be done. This product could reduce prostate biopcies by up to 50%. This could prevent the painful and sometimes infections associated with prostate biopcies. I have had prostate cancer, and I know the discomfort of this biopcy. 4Kscore could eliminate to PSA time in time. The LONG POSITION holders will jump for joy when the profits start to roll in from 4Kscore.